Co-Use of Opioid Medications and Alcohol Prevention Study

Description

Previous research, including that of this team, shows that a significant portion of those regularly using opioids-particularly filling opioids at community pharmacies-also are involved in the co-use of alcohol. This study proposes to adapt a previously developed intervention for opioid medication misuse; test its acceptability, feasibility, and preliminary efficacy; and identify barriers and facilitators to large-scale research and system-level implementation. Results of this study will directly inform a fully-powered subsequent multisite trial.

Conditions

Alcohol Drinking, Opioid Use

Study Overview

Study Details

Study overview

Previous research, including that of this team, shows that a significant portion of those regularly using opioids-particularly filling opioids at community pharmacies-also are involved in the co-use of alcohol. This study proposes to adapt a previously developed intervention for opioid medication misuse; test its acceptability, feasibility, and preliminary efficacy; and identify barriers and facilitators to large-scale research and system-level implementation. Results of this study will directly inform a fully-powered subsequent multisite trial.

Co-Use of Opioid Medications and Alcohol Prevention Study (COAPS)

Co-Use of Opioid Medications and Alcohol Prevention Study

Condition
Alcohol Drinking
Intervention / Treatment

-

Contacts and Locations

Nashville

University of Tennessee College of Medicine, Nashville, Tennessee, United States, 38103

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * English speaking
  • * ≥18 years
  • * Not receiving cancer treatment
  • * Current alcohol use
  • * Prescribed an opioid medication
  • * SA 2 exclusion
  • * Are pregnant
  • * Cannot provide collateral contact information for ≥2 persons
  • * Do not have a reliable land line or mobile phone to be contacted by study staff
  • * Are filling only buprenorphine
  • * Plan to leave the area for an extended period of time in the next 3-months, or
  • * Have experienced a psychotic and/or manic episode in the last 30 days

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Utah,

Study Record Dates

2025-04-30